ADHADODA*VASIKA 250MG CAPSULE

Indications

• Asthma
• Chronic bronchitis
• Cough
• Respiratory tract infections

Dosage

Children: Refer to established guidelines or consult a healthcare professional for specific dosing information, as it may vary based on the formulation and condition being treated.

Adults: Refer to established guidelines or consult a healthcare professional for specific dosing information, as it may vary based on the formulation and condition being treated.

Mechanism of action

The active components of Adhatoda vasica, particularly vasicine and vasicinone, exert their effects by relaxing the bronchial muscles and reducing inflammation in the airways. These compounds inhibit the release of histamines and other mediators of inflammation, leading to bronchodilation and improved airflow. They also promote mucosal secretion, which helps in the expulsion of mucus from the respiratory tract.

Pharmacodynamics

Adhadoda exhibits a range of pharmacological activities, including bronchodilation, anti-inflammatory effects, and mucolytic properties. The plant's extracts have been shown to improve respiratory function and reduce the severity of cough in conditions like asthma and chronic obstructive pulmonary disease (COPD). Its antitussive action helps in alleviating cough by acting on the cough center in the brain.

Pharmacokinetics

The pharmacokinetic profile of Adhadoda extracts is not well-documented in clinical settings. However, studies suggest that the active constituents are absorbed through the gastrointestinal tract when taken orally. The onset of action may vary, but effects are generally observed within a few hours. The metabolites of vasicine are believed to be excreted through urine, although detailed studies on metabolism and excretion are limited.

Adverse effects

• Nausea
• Vomiting
• Drowsiness
• Dizziness
• Dry mouth

Precautions

• Use with caution in patients with liver disease
• Monitor for potential sedation when combined with central nervous system depressants

Pregnancy

Safety in pregnancy has not been established; use with caution.

Breast-feeding

It is not known if adhadoda is excreted in human milk; caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Powder
• Capsules
• Liquid extract

Indications

• Asthma
• Bronchitis
• Cough
• Chronic obstructive pulmonary disease (COPD)
• Respiratory tract infections

Dosage

Children: Refer to established herbal dosage guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established herbal dosage guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The mechanism of action of Vasika is attributed mainly to its active constituents, particularly Vasicine. Vasicine acts as a bronchial muscle relaxant and has been shown to inhibit certain inflammatory pathways. It may also exert expectorant effects by stimulating mucus secretion and enhancing mucociliary function, thereby facilitating the clearance of respiratory secretions.

Pharmacodynamics

Vasika exhibits several pharmacodynamic effects including bronchodilation, reduction of mucus viscosity, and anti-inflammatory actions. These properties help alleviate symptoms associated with respiratory disorders, improving airflow and reducing coughing episodes. The herb's constituents can also modulate immune responses in the respiratory tract.

Pharmacokinetics

The pharmacokinetics of Vasika, particularly its absorption, distribution, metabolism, and excretion, are not extensively documented in the literature. However, it is generally understood that the bioactive compounds are absorbed through the gastrointestinal tract, distributed to various tissues, and metabolized primarily in the liver. The exact half-life and excretion pathways remain less defined.